Related Experiment Video

Updated: Jul 12, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

l-Dgr9-trans-Tetrahydrocannabinol in Pigeons: Tolerance to the Behavioral Effects

D E McMillan, L S Harris, J M Frankenheim

    Science (New York, N.Y.)
    |July 31, 1970
    PubMed

    Keywords:
    behavioral pharmacologycannabinoid toleranceavian modelsdrug adaptation

    More Related Videos

    Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

    Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

    Published on: February 28, 2025

    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates06:09

    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

    Published on: May 30, 2025

    Related Concept Videos

    Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

    Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

    Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
    Two synthetic agonists of THC,...